Paper39944690
Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development.
Ke Z and 9 others. Front Immunol, 2025. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development. Papers, record 39944690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39944690
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sirtuins | Major topic |
| Neoplasms | Major topic |
| Protein Processing, Post-Translational | Major topic |
| Mitochondria | Major topic |
| Succinic Acid | Major topic |
| Humans | |
| Animals |
Source PubMed
References171
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34476599 | Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer. | Arch Gynecol Obstet | 2022 | https://conductscience.org/library/papers/34476599 | PubMed |
| 2 | 34765287 | Role of succinylation modification in thyroid cancer and breast cancer. | Am J Cancer Res | 2021 | https://conductscience.org/library/papers/34765287 | PubMed |
| 3 | 37789393 | LINC00922 decoys SIRT3 to facilitate the metastasis of colorectal cancer through up-regulation the H3K27 crotonylation of ETS1 promoter. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37789393 | PubMed |
| 4 | 36646410 | The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer. | Cancer Lett | 2023 | https://conductscience.org/library/papers/36646410 | PubMed |
| 5 | 27291931 | SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia. | Sci Rep | 2016 | https://conductscience.org/library/papers/27291931 | PubMed |
| 6 | 26819452 | Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26819452 | PubMed |
| 7 | 33103371 | Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl-CoA acetyltransferase 1. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/33103371 | PubMed |
| 8 | 31572453 | Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer. | Front Genet | 2019 | https://conductscience.org/library/papers/31572453 | PubMed |
| 9 | 35182732 | Overexpression of SLC25A51 promotes hepatocellular carcinoma progression by driving aerobic glycolysis through activation of SIRT5. | Free Radic Biol Med | 2022 | https://conductscience.org/library/papers/35182732 | PubMed |
| 10 | 38773972 | Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies. | Theranostics | 2024 | https://conductscience.org/library/papers/38773972 | PubMed |
| 11 | 37819759 | Loss of succinyl-CoA synthetase in mouse forebrain results in hypersuccinylation with perturbed neuronal transcription and metabolism. | Cell Rep | 2023 | https://conductscience.org/library/papers/37819759 | PubMed |
| 12 | 37580347 | HDAC1/2/3 are major histone desuccinylases critical for promoter desuccinylation. | Cell Discov | 2023 | https://conductscience.org/library/papers/37580347 | PubMed |
| 13 | 28631845 | Mild metabolic perturbations alter succinylation of mitochondrial proteins. | J Neurosci Res | 2017 | https://conductscience.org/library/papers/28631845 | PubMed |
| 14 | 29180469 | SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation. | Cancer Res | 2018 | https://conductscience.org/library/papers/29180469 | PubMed |
| 15 | 33872694 | SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33872694 | PubMed |
| 16 | 30523058 | Structural insights into the molecular mechanism underlying Sirt5-catalyzed desuccinylation of histone peptides. | Biochem J | 2019 | https://conductscience.org/library/papers/30523058 | PubMed |
| 17 | 27783945 | The SIRT2 Deacetylase Stabilizes Slug to Control Malignancy of Basal-like Breast Cancer. | Cell Rep | 2016 | https://conductscience.org/library/papers/27783945 | PubMed |
| 18 | 39145876 | SIRT5 suppresses the trophoblast cell proliferation, invasion, and migration to promote preeclampsia via desuccinylating HOXB3. | J Assist Reprod Genet | 2024 | https://conductscience.org/library/papers/39145876 | PubMed |
| 19 | 37063423 | SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37063423 | PubMed |
| 20 | 36814349 | Core-predominant gut fungus Kazachstania slooffiae promotes intestinal epithelial glycolysis via lysine desuccinylation in pigs. | Microbiome | 2023 | https://conductscience.org/library/papers/36814349 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985052 | Advances in Novel Protein Acylation in Urothelial Carcinoma: Research Progress and Biomarker Potential. | Oncol Res | 2026 | https://conductscience.org/library/papers/42985052 | PubMed |
| 42755804 | The expression and clinical significance of SIRT5, H2A and TOP2A in cervical cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42755804 | PubMed |
| 42755457 | The role of lysine acylation in metabolic dysregulation and inflammatory responses within the hepatic immune microenvironment of MASLD. | Front Immunol | 2026 | https://conductscience.org/library/papers/42755457 | PubMed |
| 42750984 | When metabolic enzymes meet lactylation: a bidirectional dialogue in health and disease. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42750984 | PubMed |
| 42750209 | Aspirin-Derived Salicyl-CoA Drives Histone Lysine Salicylation Regulated by CBP and SIRT2. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42750209 | PubMed |
| 42584557 | Protective mechanisms of Sirtuin Family in myocardial ischemia-reperfusion injury and translational therapeutic perspectives. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42584557 | PubMed |
| 42489764 | SIRT5 Attenuates Doxorubicin-Induced Acute Cardiac Injury by Modulating PHB2 Succinylation and the Mitophagic Response. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/42489764 | PubMed |
| 42472512 | SIRT7-mediated desuccinylation of FOXO4 suppresses ferroptosis to alleviate LPS-induced acute lung injury. | Redox Biol | 2026 | https://conductscience.org/library/papers/42472512 | PubMed |
| 42163139 | Beyond deacetylation: crosstalk mechanisms and context-dependent regulation of sirtuin non-classical enzymatic functions in disease. | Mol Med | 2026 | https://conductscience.org/library/papers/42163139 | PubMed |
| 42156901 | Decoding the crosstalk between ubiquitination and other post-translational modifications in cancer immunity: from mechanisms to clinical prospects. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42156901 | PubMed |
| 41828762 | Succinylation: A Functional Nexus Between Metabolic Reprogramming and Epigenetic Modifications in Cancer. | Molecules | 2026 | https://conductscience.org/library/papers/41828762 | PubMed |
| 41788628 | Succinylation: novel molecular mechanisms and prospects for targeted therapy in liver diseases. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/41788628 | PubMed |
| 41549306 | Targeting MFF succinylation: a novel therapeutic strategy for premature ovarian insufficiency by restoring mitochondrial dynamics in granulosa cells. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/41549306 | PubMed |
| 41498691 | SIRT5-RAC2 Axis Drives Monocyte-to-Macrophage Differentiation to Promote Inflammatory Injury in Premature Ovarian Insufficiency. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41498691 | PubMed |
| 41003805 | The role of succinylation-mediated metabolic reprogramming in tumor progression. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41003805 | PubMed |
| 40754534 | Mitochondrial metabolism and cancer therapeutic innovation. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40754534 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SIRT5 | 23408 | PubTator's text mining | https://conductscience.org/library/genes/23408 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39944690
GET https://conductscience.org/api/papers/v1/39944690/references?page=2